术前补充钙和骨化三醇能否降低甲状腺切除术后低钙血症?一项随机临床试验
该单中心前瞻性随机试验纳入82例全甲状腺切除术患者,比较术前5天开始钙和骨化三醇补充与仅术后补充对术后低钙血症的影响。结果显示干预组低钙血症发生率为13.2%,对照组为15.9%(p=0.76),无显著差异;次要结局如术后钙水平、干预需求、住院时间和再入院率亦无差异。结论不支持全甲状腺切除术前常规补充钙和骨化三醇。
要点
- 术前5天开始补充钙和骨化三醇未降低全甲状腺切除术后低钙血症发生率。
- 干预组与对照组低钙血症发生率分别为13.2%和15.9%,无统计学差异。
- 次要结局包括术后钙水平、干预需求、住院时间和再入院率均无显著差异。
核心结论
- 全甲状腺切除术前开始补充钙和骨化三醇与仅术后补充相比,并未降低术后低钙血症的发生率。
研究设计与样本
- 单中心前瞻性随机临床试验,纳入2017年7月至2019年5月行全甲状腺切除术的82例患者,排除部分甲状腺切除或同期计划甲状旁腺切除者。
主要发现
- 干预需求干预组10例(26.3%),对照组15例(34.1%),p=0.48。
- 住院时间干预组平均32.3小时(SD 15.6),对照组30.7小时(SD 10.5),p=0.6。
- 再入院干预组0例(0.0%),对照组3例(6.8%),p=0.24。
关键数值与推荐
- 干预组术前5天开始口服骨化三醇0.25 μg bid和碳酸钙1,500 mg tid,并持续至术后;对照组仅术后开始相同药物。
- 主要终点为临床或生化低钙血症。
临床怎么用
- 基于本试验结果,不支持全甲状腺切除术前常规预防性补充钙和骨化三醇。
局限性
- 单中心研究,样本量较小(82例),可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative hypocalcemia is the most common complication after thyroidectomy. Postoperative supplementation with calcium and calcitriol reduces its occurrence; however, prophylactic preoperative supplementation has not been studied systematically. The primary objective of this study was to determine whether pre- and postoperative calcium and calcitriol supplementation reduces postoperative hypocalcemia after total thyroidectomy compared with postoperative supplementation alone. STUDY DESIGN: We conducted a single-institution prospective randomized trial enrolling 82 patients undergoing total thyroidectomy from July 2017 through May 2019. Those undergoing partial thyroidectomy or concurrent planned parathyroidectomy were excluded. The intervention group started calcitriol 0.25 μg po bid and calcium carbonate 1,500 mg po tid 5 days preoperatively and continued postoperatively. The control group started these medications postoperatively. The primary end point was clinical or biochemical hypocalcemia. Secondary outcomes were postoperative calcium levels, need for intervention, length of stay, and readmission. RESULTS: Thirty-eight patients were randomized to the intervention group and 44 to the control group. There were 12 episodes of hypocalcemia; 5 (13.2%) in the intervention and 7 (15.9%) in the control group (p = 0.76). No differences were found in secondary outcomes; including postoperative calcium levels at each measured time point, need for intervention (n = 10 [26.3%], n = 15 [34.1%]; p = 0.48), length of stay (mean [SD] 32.3 [15.6] hours, 30.7 [10.5] hours; p = 0.6), or readmissions (n = 0 [0.0%], n = 3 [6.8%]; p = 0.24). CONCLUSIONS: Starting supplementation with calcium and calcitriol preoperatively does not reduce postoperative hypocalcemia compared with postoperative supplementation alone after total thyroidectomy. These findings do not support the practice of routine calcium and calcitriol supplementation before total thyroidectomy.
引用
- Donahue C, Pantel HJ, Yarlagadda BB, et al. Does Preoperative Calcium and Calcitriol Decrease Rates of Post-Thyroidectomy Hypocalcemia? A Randomized Clinical Trial. J Am Coll Surg. 2021. PMID: 33631337. doi:10.1016/j.jamcollsurg.2021.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。